Point of Care (POC) Infectious Disease Diagnostic Testing Market

    Published: March 22, 2018 | Price: $2,995.00 – $5,995.00

    This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas Influenza STD HIV Hepatitis Malaria C. difficile E. coli H. pylori Home Test/OTC Others Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players.  As part of its coverage, the report also profiles competitors in the market, including the following: Abbott/Alere Atlas Genetics Ltd. Atlas Link Biotech Co., Ltd...
    Point-of-Care Glucose Monitoring Market: World Market Analysis

    Published: March 21, 2018 | Price: $1,500.00 – $3,000.00

    This report provides market estimates and forecasts for point-of-care glucose testing.  Information in this report is from the latest published figures for companies participating in the market as well as recent interviews.  The following markets analysis is provided in this report:  Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)   POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW)   Global POC Glucose Self-Testing Market (includes continuous glucose devices)  ...
    Infectious Disease Diagnostic Testing: World Market Analysis of TB, Flu, HIV, Hepatitis, Strep A, Malaria, HPV, Blood Screening, STDs, ID/AST, HAI, Rapids and Other Test Products

    Published: February 26, 2018 | Price: $5,500.00 – $11,000.00

    Infectious Disease Testing: World Market Analysis (HIV, Hepatitis, Blood Screening With over 400 tables to illustrate the analysis and provide solid business planning metrics, The World Market for Infectious Disease Diagnostic Diagnostics Testing, covers 30 areas of infectious diseases in 25 countries and regions.  Diseases and technology categories segmented and forecasted in this report include: Blood Screening Immunoassay Blood Screening NAT Influenza Tests Strep A Test RSV Testing Malaria Tests Dengue Testing HIV Tests – Laboratories HIV Tests – POC...
    The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)

    Published: February 16, 2018 | Price: $3,995.00 – $7,990.00

    What is the Size of the Point of Care Diagnostic Testing Market?   This report provides an in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will...
    The Market and Potential for Molecular Point of Care Diagnostic Tests

    Published: January 25, 2018 | Price: $3,995.00 – $7,900.00

    THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/   Among the various technologies and products of the global in vitro diagnostics (IVD) market, molecular diagnostics performed at the point of care or near the patient are regarded as a leading expansion market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics,...
    Direct-to-Consumer Testing Market

    Published: January 14, 2018 | Price: $4,500.00 – $9,000.00

    With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare. The global DTC testing market is divided into two distinct areas of DTC testing: Routine clinical laboratory testing Medical genetic laboratory testing Kalorama’s...
    The Market for Direct-to-Consumer Genetic Health Testing

    Published: January 10, 2018 | Price: $4,200.00 – $7,990.00

    The Market for Direct-to-Consumer Genetic Health Testing The Market for Direct-to-Consumer Genetic Health Testing provides an overview of the laboratory testing industry for advanced genetic tests. Market trends covered include world DTC genetic testing revenues, 2017-2022; revenues and growth for the U.S. European, Asia Pacific, and rest of world DTC genetic testing market, 2017-2022; genetic testing market drivers and barriers; and global DTC genetic testing market analysis featuring genetic testing volume distribution for genetic testing services by order origination source...
    Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)

    Published: January 8, 2018 | Price: $2,995.00 – $5,990.00

    Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)Tumor Markers Immunoassay Market analyzes the current world market, including tumor markers immunoassay revenues by marker, 2015-2025 (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total); regional revenues for tumor markers immunoassays, 2015-2025 (US, EU, ROW, Total); attributes of selected tumor marker immunoassays (cancer type, tissue analyzed, how used); and selected...
    Inherited Disease and Molecular Diagnostics Bundle 2017

    Published: December 20, 2017 | Price: $2,640.00 – $5,280.00

    Bundle of report sections including Molecular Assay Procedures Inherited Disease Markets Cancer Markers
    Expected High Growth Market Segments in Molecular Diagnostic Testing

    Published: December 14, 2017 | Price: $2,000.00 – $4,000.00

    Expected High Growth Market Segments in Molecular Diagnostic Testing Tests for hepatitis, nucleic acid blood testing and respiratory testing are among the fast-growing segments of molecular testing in 2018, according to a new report from Kalorama Information.   will exceed the average for revenue growth in molecular IVD, according to a new Kalorama Information report.  Average molecular IVD products will see six percent growth, the areas identified will be higher, over the next five years.   These are among the findings in...
    Human Microbiome Applications in IVD and Other Healthcare

    Published: December 6, 2017 | Price: $1,200.00 – $2,400.00

    Human Microbiome Applications in IVD and Other Healthcare Human Microbiome Applications in IVD and Other Healthcare examines the growing interest in the human microbiome in in vitro diagnostics and other healthcare applications. This report notes IVD company interest in the microbiome, including selected microbiome-based tests, including selected molecular tests; microbiome-based diagnostic biomarkers; and precision or personalized medicine approaches to the microbiome. Human Microbiome Applications in IVD and Other Healthcare notes pharmaceutical company interest in the microbiome as well. Discussed are...
    HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC])

    Published: October 25, 2017 | Price: $3,600.00 – $7,200.00

    HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including: Global HIV Testing Market, 2015-2022 (in millions at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of the global HIV testing market – lab-based immunoassay HIV testing,...
    Selected New Products in IVD

    Published: October 19, 2017 | Price: $200.00 – $400.00

    New products in IVD, as launched at major diagnostic conventions.
    Clinical Chemistry Markets (by Type [Instrument, Reagent], by Analyte [Glucose, Electrolytes, Cardiac Biomarkers, Enzymes, Proteins, Drugs of Abuse, Therapeutic Drugs, HbA1c, Others], by Region)

    Published: October 16, 2017 | Price: $3,600.00 – $7,200.00

    Clinical Chemistry Markets (by Type [Instrument, Reagent], by Analyte [Glucose Market, Electrolytes Market, Cardiac Biomarkers Market, Enzymes Market, Proteins Market, Drugs of Abuse Market, Therapeutic Drugs Market, HbA1c Market, Other Commonly Tested Analytes] by Region) This Kalorama Information report, Clinical Chemistry Markets, examines the global market for clinical chemistry products and procedures. Among the products covered are instruments, reagents, and supporting consumables used worldwide in core laboratory and point-of-care (POC) medical testing. Clinical chemistry instruments consist of large multifunctional workstations...
    The Market for Inherited Disease Molecular Diagnostic Testing

    Published: October 13, 2017 | Price: $2,000.00 – $4,000.00

    The Market for Inherited Disease Molecular Diagnostic Testing The detection of single nucleotide polymorphisms (SNPs) or gene variants from tissue, blood, urine and saliva samples can be used to diagnose inherited diseases and genetic disorders as well as determine the risk of disease manifestation or progression. Point mutations in genomic DNA occur when a single nucleotide (A,T,C, or G) sequence is altered. Many SNPs have no effect on cell function, but scientists believe others could predispose people to disease or...